The next generation sequencing market size has grown rapidly in recent years. It will grow from $14.2 billion in 2025 to $16.31 billion in 2026 at a compound annual growth rate (CAGR) of 14.9%. The growth in the historic period can be attributed to increasing research activity in genomics, declining costs of sequencing technologies, expansion of molecular diagnostics laboratories, rising demand for disease-associated genetic analysis, availability of advanced sequencing reagents.
The next generation sequencing market size is expected to see rapid growth in the next few years. It will grow to $28.59 billion in 2030 at a compound annual growth rate (CAGR) of 15.1%. The growth in the forecast period can be attributed to increasing adoption of precision medicine initiatives, rising investments in population genomics studies, expansion of NGS in oncology diagnostics, growing demand for rapid sequencing solutions, increasing integration of sequencing data with clinical decision systems. Major trends in the forecast period include increasing adoption of high-throughput sequencing platforms, rising demand for clinical diagnostic sequencing, growing integration of ai-based bioinformatics tools, expansion of targeted and personalized medicine applications, enhanced focus on cost-effective sequencing workflows.
The rising demand for personalized medicine is anticipated to drive the expansion of the next-generation sequencing market in the coming years. Personalized medicine, also referred to as precision medicine, represents an innovative approach to healthcare and treatment that considers an individual's distinct genetic, environmental, and lifestyle characteristics to customize medical decisions and therapies. Next-generation sequencing serves as a core technology in personalized medicine, enabling accurate analysis of a person’s genetic profile and the creation of tailored healthcare plans. For example, in February 2024, the Personalised Medicine Coalition, a US-based hospital and healthcare organization, reported that in 2023, the FDA approved 16 new personalized treatments for patients with rare diseases, compared to six approvals in 2022. Consequently, the growing demand for personalized medicine is fueling the growth of the next-generation sequencing market.
Major companies in the next-generation sequencing market are concentrating on developing advanced technologies such as hybrid long- and short-read sequencing to improve genomic resolution and accuracy. Hybrid long- and short-read sequencing integrates the high throughput and low error rates of short reads with the structural insights and coverage advantages of long reads. For example, in March 2023, Illumina, a US-based biotechnology firm, introduced the Illumina Complete Long Read Prep, Human assay, featuring its innovative Complete Long Read technology. The assay allows both long- and short-read data to be generated on the same Illumina instrument and is fully compatible with NovaSeq X Plus, NovaSeq X, and NovaSeq 6000 systems. Its primary features include a simplified workflow with significantly lower DNA input requirements compared to other long-read platforms, integration of Illumina sequencing-by-synthesis (SBS) chemistry with DRAGEN secondary analysis for highly accurate whole-genome sequencing, access to difficult-to-map and complex genic regions, and a promotional cost of US $1,350 per genome (on NovaSeq X Plus with a 25B flow cell), covering long- and short-read library prep, sequencing, and cloud analysis.
In September 2025, SeqOne, a France-based provider of AI-powered genomic analysis platforms, acquired Congenica for an undisclosed sum. With this acquisition, SeqOne intends to combine its AI-driven Next-Generation Sequencing (NGS) capabilities with Congenica’s clinical decision support and genomic interpretation technologies, enhancing its global position in AI-powered genomic medicine and speeding up the delivery of accurate, personalized diagnostics. Congenica is a UK-based digital health company that provides clinical decision-support solutions and genomic interpretation services to hospitals and research organizations worldwide.
Major companies operating in the next generation sequencing market are Illumina Inc, Thermo Fisher Scientific Inc, Pacific Biosciences of California Inc, Oxford Nanopore Technologies Ltd, QIAGEN NV, Agilent Technologies Inc, PerkinElmer Inc, BGI Group, 10x Genomics Inc, Takara Bio Inc, New England Biolabs Inc, Twist Bioscience Corp, Element Biosciences Inc, Ultima Genomics Inc, SeqWell Inc, Integrated DNA Technologies Inc, LGC Limited, Bio‑Rad Laboratories Inc, Zymo Research Corporation, NimaGen BV.
North America was the largest region in the next generation sequencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the next generation sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the next generation sequencing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the next generation sequencing market by increasing costs of imported sequencing instruments, reagents, flow cells, and analytical software components. Research institutions and diagnostic laboratories in North America and Europe are most affected due to dependence on imported high-end sequencing platforms, while Asia-Pacific faces cost pressures on reagent manufacturing and exports. These tariffs are increasing operational costs and slowing equipment upgrades. At the same time, they are encouraging regional reagent production, localized instrument assembly, and greater investment in domestic genomics infrastructure.
The next generation sequencing market research report is one of a series of new reports that provides next generation sequencing market statistics, including next generation sequencing industry global market size, regional shares, competitors with a next generation sequencing market share, detailed next generation sequencing market segments, market trends and opportunities, and any further data you may need to thrive in the next generation sequencing industry. This next generation sequencing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Next-generation sequencing is a sequencing technology that provides ultra-high throughput, scalability, and speed, and is utilized to determine the genetic variation associated with diseases or other biological phenomena.
The primary products in the next-generation sequencing market include NextSeq systems, MiniSeq systems, NovaSeq systems, iSeq 100 systems, ion PGM Systems, Ion Proton systems, ion GeneStudio S5 systems, PacBio RS II Systems, Sequel systems, and others. The MiniSeq system combines load-and-go operation with an intuitive user interface for a fast and easy NGS workflow. It integrates clonal amplification, sequencing through synthesis, and base calling into a single benchtop instrument, eliminating the need for additional equipment. Various technologies in next-generation sequencing include sequencing by synthesis, ion semiconductor sequencing, single-molecule real-time sequencing, nanopore sequencing, and other sequencing technologies applied in diagnostics, drug discovery, and other applications.
The next generation sequencing market consist of sales of genetic sequencing equipment with advanced features and technologies such as ion semiconductor sequencing, nano-pore sequencing, single-molecule real-time sequencing, and other technologies that are used for next generation sequencing. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The next generation sequencing market size is expected to see rapid growth in the next few years. It will grow to $28.59 billion in 2030 at a compound annual growth rate (CAGR) of 15.1%. The growth in the forecast period can be attributed to increasing adoption of precision medicine initiatives, rising investments in population genomics studies, expansion of NGS in oncology diagnostics, growing demand for rapid sequencing solutions, increasing integration of sequencing data with clinical decision systems. Major trends in the forecast period include increasing adoption of high-throughput sequencing platforms, rising demand for clinical diagnostic sequencing, growing integration of ai-based bioinformatics tools, expansion of targeted and personalized medicine applications, enhanced focus on cost-effective sequencing workflows.
The rising demand for personalized medicine is anticipated to drive the expansion of the next-generation sequencing market in the coming years. Personalized medicine, also referred to as precision medicine, represents an innovative approach to healthcare and treatment that considers an individual's distinct genetic, environmental, and lifestyle characteristics to customize medical decisions and therapies. Next-generation sequencing serves as a core technology in personalized medicine, enabling accurate analysis of a person’s genetic profile and the creation of tailored healthcare plans. For example, in February 2024, the Personalised Medicine Coalition, a US-based hospital and healthcare organization, reported that in 2023, the FDA approved 16 new personalized treatments for patients with rare diseases, compared to six approvals in 2022. Consequently, the growing demand for personalized medicine is fueling the growth of the next-generation sequencing market.
Major companies in the next-generation sequencing market are concentrating on developing advanced technologies such as hybrid long- and short-read sequencing to improve genomic resolution and accuracy. Hybrid long- and short-read sequencing integrates the high throughput and low error rates of short reads with the structural insights and coverage advantages of long reads. For example, in March 2023, Illumina, a US-based biotechnology firm, introduced the Illumina Complete Long Read Prep, Human assay, featuring its innovative Complete Long Read technology. The assay allows both long- and short-read data to be generated on the same Illumina instrument and is fully compatible with NovaSeq X Plus, NovaSeq X, and NovaSeq 6000 systems. Its primary features include a simplified workflow with significantly lower DNA input requirements compared to other long-read platforms, integration of Illumina sequencing-by-synthesis (SBS) chemistry with DRAGEN secondary analysis for highly accurate whole-genome sequencing, access to difficult-to-map and complex genic regions, and a promotional cost of US $1,350 per genome (on NovaSeq X Plus with a 25B flow cell), covering long- and short-read library prep, sequencing, and cloud analysis.
In September 2025, SeqOne, a France-based provider of AI-powered genomic analysis platforms, acquired Congenica for an undisclosed sum. With this acquisition, SeqOne intends to combine its AI-driven Next-Generation Sequencing (NGS) capabilities with Congenica’s clinical decision support and genomic interpretation technologies, enhancing its global position in AI-powered genomic medicine and speeding up the delivery of accurate, personalized diagnostics. Congenica is a UK-based digital health company that provides clinical decision-support solutions and genomic interpretation services to hospitals and research organizations worldwide.
Major companies operating in the next generation sequencing market are Illumina Inc, Thermo Fisher Scientific Inc, Pacific Biosciences of California Inc, Oxford Nanopore Technologies Ltd, QIAGEN NV, Agilent Technologies Inc, PerkinElmer Inc, BGI Group, 10x Genomics Inc, Takara Bio Inc, New England Biolabs Inc, Twist Bioscience Corp, Element Biosciences Inc, Ultima Genomics Inc, SeqWell Inc, Integrated DNA Technologies Inc, LGC Limited, Bio‑Rad Laboratories Inc, Zymo Research Corporation, NimaGen BV.
North America was the largest region in the next generation sequencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the next generation sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the next generation sequencing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the next generation sequencing market by increasing costs of imported sequencing instruments, reagents, flow cells, and analytical software components. Research institutions and diagnostic laboratories in North America and Europe are most affected due to dependence on imported high-end sequencing platforms, while Asia-Pacific faces cost pressures on reagent manufacturing and exports. These tariffs are increasing operational costs and slowing equipment upgrades. At the same time, they are encouraging regional reagent production, localized instrument assembly, and greater investment in domestic genomics infrastructure.
The next generation sequencing market research report is one of a series of new reports that provides next generation sequencing market statistics, including next generation sequencing industry global market size, regional shares, competitors with a next generation sequencing market share, detailed next generation sequencing market segments, market trends and opportunities, and any further data you may need to thrive in the next generation sequencing industry. This next generation sequencing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Next-generation sequencing is a sequencing technology that provides ultra-high throughput, scalability, and speed, and is utilized to determine the genetic variation associated with diseases or other biological phenomena.
The primary products in the next-generation sequencing market include NextSeq systems, MiniSeq systems, NovaSeq systems, iSeq 100 systems, ion PGM Systems, Ion Proton systems, ion GeneStudio S5 systems, PacBio RS II Systems, Sequel systems, and others. The MiniSeq system combines load-and-go operation with an intuitive user interface for a fast and easy NGS workflow. It integrates clonal amplification, sequencing through synthesis, and base calling into a single benchtop instrument, eliminating the need for additional equipment. Various technologies in next-generation sequencing include sequencing by synthesis, ion semiconductor sequencing, single-molecule real-time sequencing, nanopore sequencing, and other sequencing technologies applied in diagnostics, drug discovery, and other applications.
The next generation sequencing market consist of sales of genetic sequencing equipment with advanced features and technologies such as ion semiconductor sequencing, nano-pore sequencing, single-molecule real-time sequencing, and other technologies that are used for next generation sequencing. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Next Generation Sequencing Market Characteristics
3. Next Generation Sequencing Market Supply Chain Analysis
4. Global Next Generation Sequencing Market Trends and Strategies
5. Next Generation Sequencing Market Analysis of End Use Industries
7. Global Next Generation Sequencing Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Next Generation Sequencing Total Addressable Market (TAM) Analysis for the Market
9. Next Generation Sequencing Market Segmentation
10. Next Generation Sequencing Market Regional and Country Analysis
11. Asia-Pacific Next Generation Sequencing Market
12. China Next Generation Sequencing Market
13. India Next Generation Sequencing Market
14. Japan Next Generation Sequencing Market
15. Australia Next Generation Sequencing Market
16. Indonesia Next Generation Sequencing Market
17. South Korea Next Generation Sequencing Market
18. Taiwan Next Generation Sequencing Market
19. South East Asia Next Generation Sequencing Market
20. Western Europe Next Generation Sequencing Market
21. UK Next Generation Sequencing Market
22. Germany Next Generation Sequencing Market
23. France Next Generation Sequencing Market
24. Italy Next Generation Sequencing Market
25. Spain Next Generation Sequencing Market
26. Eastern Europe Next Generation Sequencing Market
27. Russia Next Generation Sequencing Market
28. North America Next Generation Sequencing Market
29. USA Next Generation Sequencing Market
30. Canada Next Generation Sequencing Market
31. South America Next Generation Sequencing Market
32. Brazil Next Generation Sequencing Market
33. Middle East Next Generation Sequencing Market
34. Africa Next Generation Sequencing Market
36. Next Generation Sequencing Market Competitive Landscape and Company Profiles
37. Next Generation Sequencing Market Other Major and Innovative Companies
40. Next Generation Sequencing Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Next Generation Sequencing Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses next generation sequencing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for next generation sequencing? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The next generation sequencing market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Instruments; Reagents And Kits; Software2) By Technology: Sequencing by Synthesis; Ion Semiconductor Sequencing; Single-molecule Real-time Sequencing; Nanopore Sequencing; Other Sequencing Technologies
3) By Application: Diagnostics; Drug Discovery; Other Applications
Subsegments:
1) By Instruments: Sequencing Systems; Library Preparation Instruments; Quality Control Instruments2) By Reagents And Kits: Sequencing Reagents; Library Preparation Kits; Amplification Kits
3) By Software: Data Analysis Software; Bioinformatics Software; Workflow Management Software
Companies Mentioned: Illumina Inc; Thermo Fisher Scientific Inc; Pacific Biosciences of California Inc; Oxford Nanopore Technologies Ltd; QIAGEN NV; Agilent Technologies Inc; PerkinElmer Inc; BGI Group; 10x Genomics Inc; Takara Bio Inc; New England Biolabs Inc; Twist Bioscience Corp; Element Biosciences Inc; Ultima Genomics Inc; SeqWell Inc; Integrated DNA Technologies Inc; LGC Limited; Bio‑Rad Laboratories Inc; Zymo Research Corporation; NimaGen BV
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Next Generation Sequencing market report include:- Illumina Inc
- Thermo Fisher Scientific Inc
- Pacific Biosciences of California Inc
- Oxford Nanopore Technologies Ltd
- QIAGEN NV
- Agilent Technologies Inc
- PerkinElmer Inc
- BGI Group
- 10x Genomics Inc
- Takara Bio Inc
- New England Biolabs Inc
- Twist Bioscience Corp
- Element Biosciences Inc
- Ultima Genomics Inc
- SeqWell Inc
- Integrated DNA Technologies Inc
- LGC Limited
- Bio‑Rad Laboratories Inc
- Zymo Research Corporation
- NimaGen BV
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 16.31 Billion |
| Forecasted Market Value ( USD | $ 28.59 Billion |
| Compound Annual Growth Rate | 15.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
